Big Move For AnPac Bio-Medical Science Co., Ltd.
AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ) soared at $8.61, representing a gain of 49.2%. On Mon 08 Mar 21, ANPC:NASDAQ hit a New 2-Week Low of $5.77. The stock appeared on our News Catalysts scanner on Tue 09 Mar 21 at 08:44 AM in the 'BIOTECH' category. From Mon 22 Feb 21, the stock recorded 20.00% Up Days and 36.36% Green Days
The stock spiked on Wed 17 Feb 21 at $8.23 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ)
AnPac Bio-Medical Science Co Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative, patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated potential to assist physicians in cancer diagnosis, prognosis and recurrence.
Top 10 Gainers:
- Exela Technologies, Inc. (XELA:NASDAQ), 179.39%
- OCAX (OCAX:NASDAQ), 100%
- Washington Prime Group Inc. (WPG:NYSE), 86.26%
- Sintx Technologies, Inc. (SINT:NASDAQ), 58.56%
- Auris Medical Holding Ltd. (EARS:NASDAQ), 52.05%
- Canaan Inc. (CAN:NASDAQ), 50.45%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 49.22%
- Oragenics, Inc. (OGEN:NYSEMKT), 47.97%
- The9 Limited (NCTY:NASDAQ), 37.13%
- ReneSola Ltd (SOL:NYSE), 36.3%